Methods for monitoring neuroinflammatory destruction of neurons and for treating diseases having an inflammatory component related to phospholipase A2
Details for Australian Patent Application No. 2006269327 (hide)
International Classifications
Event Publications
15 September 2011 Section 223 Application Received
Philadelphia Health And Education Corporation, D/b/a Drexel University College Of Medicine An application to extend the time from 08 Feb 2008 to 08 Jul 2011 in which to enter the National Phase has been filed . Address for service in Australia - Pizzeys Level 2, Woden Plaza Offices Woden Town Square Woden Canberra ACT 2606 2011
3 November 2011 Section 223 Application Allowed
Philadelphia Health And Education Corporation, D/b/a Drexel University College Of Medicine The time in which to enter the National Phase has been extended to 08 Jul 2011. Address for service in Australia - Pizzeys Level 2, Woden Plaza Offices Woden Town Square Woden Canberra ACT 2606 2008
10 November 2011 PCT application entered the National Phase
PCT publication WO2007/008690 Priority application(s): WO2007/008690
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006269331-Electronic lock actuator with helical drive member
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser